Detalhe da pesquisa
1.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
medRxiv
; 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523415
2.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Lancet Respir Med
; 11(11): 975-990, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716365
3.
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
EClinicalMedicine
; 64: 102168, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936652
4.
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity.
FASEB J
; 23(2): 442-50, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18842964
5.
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Naunyn Schmiedebergs Arch Pharmacol
; 372(4): 267-76, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16362429